Michael Hoffman, MD
Urology · Winchester, VANPI 1902907942
Payments from drug & device makers
Across 68 payments — averaging $24.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$243
- Coloplast$230
- Teva Pharmaceuticals USA, Inc.$183
- Sumitomo Pharma America, Inc.$167
- Johnson & Johnson$115
- AbbVie$100
- plus $606 from 19 others
What the payments were for
- Food & beverage$1,16571%
- Education$47929%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 11 | $243 |
| Coloplast | 12 | $230 |
| Teva Pharmaceuticals USA, Inc. | 2 | $183 |
| Sumitomo Pharma America, Inc. | 6 | $167 |
| Johnson & Johnson | 2 | $115 |
| AbbVie(2 entities) | 5 | $100 |
| Tolmar Pharmaceuticals, Inc. | 4 | $82 |
| Pfizer | 4 | $72 |
| Progenics Pharmaceuticals, Inc. | 2 | $70 |
| Tolmar, Inc. | 2 | $52 |
| Calyxo, Inc. | 1 | $39 |
| Endo Pharmaceuticals Inc. | 2 | $32 |
| Myriad Genetic Laboratories, Inc. | 2 | $27 |
| Laborie Medical Technologies Corp. | 1 | $26 |
| Blue Earth Diagnostics | 2 | $26 |
| Bard Peripheral Vascular, Inc. | 1 | $24 |
| Accord Healthcare, Inc. | 1 | $23 |
| Rochester Medical Corporation | 1 | $22 |
| Olympus America Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Cook Medical LLC | 1 | $17 |
| Urogen Pharma, Inc. | 1 | $16 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Urovant Sciences Inc | 1 | $12 |
| Neotract Inc. | 1 | $11 |
How this compares
$1,644 in reported general payments places this provider in the 35th percentile of 300 urology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 549 | $7,987 |
| Potassium Citrate ErPotassium Citrate | 42 | $6,473 |
| Testosterone | 11 | $4,331 |
| Finasteride | 241 | $2,866 |
| Methenamine Hippurate | 25 | $1,793 |
| Silodosin | 13 | $940 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 35 | $693 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $639 |
| Estradiol | 11 | $553 |
| Trimethoprim | 19 | $375 |
| Cephalexin | 76 | $290 |
| NitrofurantoinNitrofurantoin Macrocrystal | 15 | $247 |
| Ropinirole Hcl | 11 | $235 |
| Allopurinol | 33 | $224 |
| Ciprofloxacin Hcl | 46 | $191 |
Paid to pharmacies, not to this prescriber.
Other urology in Winchester
- Robert GivenVirginia Beach$8.7M
- Michael WilliamsVirginia Beach$2.7M
- Michael FabrizioVirginia Beach$1.6M
- Gregg EureVirginia Beach$1.5M
- Nilay GandhiWoodbridge$1.3M
- Jessica DelongVirginia Beach$644K
- Eugene KramolowskyRichmond$594K
- Nicolas OrtizCharlottesville$331K
- Stephen CulpCharlottesville$284K
- Michael FranksRichmond$136K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.